Dr. Ying Yuan develops methods and tools for data analysis. At #AACR26, he led a workshop on using Bayesian designs in early-phase clinical trials.

"The Bayesian Optimal Phase 2 design offers a highly-efficient, unified framework for futility and toxicity monitoring," he shared.